These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 2827263)

  • 21. [The CT image of atrophy of the head of the caudate nucleus in Huntington's chorea].
    Roth J; Havrdová E; Stiková V; Bauer J
    Cas Lek Cesk; 1996 May; 135(9):277-9. PubMed ID: 8706085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 99mTc-HMPAO scanning in focal encephalitis.
    Lancet; 1988 Jul; 2(8602):104-5. PubMed ID: 2898673
    [No Abstract]   [Full Text] [Related]  

  • 23. Is direct CT caudatometry superior to indirect parameters in confirming Huntington's disease?
    Lang C
    Neuroradiology; 1985; 27(2):161-3. PubMed ID: 3157882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atrophy of caudate nucleus in Huntington's disease measured by computed tomography.
    Roth J; Havrdová E; Růzicka E
    J Neurol; 2000 Nov; 247(11):880-1. PubMed ID: 11151423
    [No Abstract]   [Full Text] [Related]  

  • 25. Measurement of caudate nucleus area--a more accurate measurement for Huntington's disease?
    Wardlaw JM; Sellar RJ; Abernethy LJ
    Neuroradiology; 1991; 33(4):316-9. PubMed ID: 1833664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Preliminary results of 99mTc-HMPAO-SPECT studies in endogenous psychoses].
    Wilhelm KR; Schröder J; Henningsen H; Sauer H; Georgi P
    Nuklearmedizin; 1989 Jun; 28(3):88-91. PubMed ID: 2787024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single photon emission computed tomography in Huntington's chorea.
    Leblhuber F; Hoell K; Reisecker F; Gebetsberger B; Puehringer W; Trenkler E; Deisenhammer E
    Psychiatry Res; 1989 Sep; 29(3):337-9. PubMed ID: 2532751
    [No Abstract]   [Full Text] [Related]  

  • 28. Non-ketotic hyperglycaemic chorea: a SPECT study.
    Chang MH; Li JY; Lee SR; Men CY
    J Neurol Neurosurg Psychiatry; 1996 Apr; 60(4):428-30. PubMed ID: 8774410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PET scan investigations of Huntington's disease: cerebral metabolic correlates of neurological features and functional decline.
    Young AB; Penney JB; Starosta-Rubinstein S; Markel DS; Berent S; Giordani B; Ehrenkaufer R; Jewett D; Hichwa R
    Ann Neurol; 1986 Sep; 20(3):296-303. PubMed ID: 2945510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brain SPECT imaging in Huntington's disease before and after therapy with olanzapine. Case report.
    Etchebehere EC; Lima MC; Passos W; Maciel Júnior JA; Santos AO; Ramos CD; Camargo EE
    Arq Neuropsiquiatr; 1999 Sep; 57(3B):863-6. PubMed ID: 10751925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Positron emission tomography measures of benzodiazepine receptors in Huntington's disease.
    Holthoff VA; Koeppe RA; Frey KA; Penney JB; Markel DS; Kuhl DE; Young AB
    Ann Neurol; 1993 Jul; 34(1):76-81. PubMed ID: 8390806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebral metabolism of glucose in benign hereditary chorea.
    Suchowersky O; Hayden MR; Martin WR; Stoessl AJ; Hildebrand AM; Pate BD
    Mov Disord; 1986; 1(1):33-44. PubMed ID: 2973557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Normal caudate glucose metabolism in persons at risk for Huntington's disease.
    Young AB; Penney JB; Starosta-Rubinstein S; Markel D; Berent S; Rothley J; Betley A; Hichwa R
    Arch Neurol; 1987 Mar; 44(3):254-7. PubMed ID: 2950844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of [99mTc]HMPAO SPECT with [18F]fluoromethane PET in cerebrovascular disease.
    Heiss WD; Herholz K; Podreka I; Neubauer I; Pietrzyk U
    J Cereb Blood Flow Metab; 1990 Sep; 10(5):687-97. PubMed ID: 2384541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of somatosensory evoked potentials with striatal glucose consumption measured by positron emission tomography in the early diagnosis of Huntington's disease.
    Kuwert T; Noth J; Scholz D; Schwarz M; Lange HW; Töpper R; Herzog H; Aulich A; Feinendegen LE
    Mov Disord; 1993; 8(1):98-106. PubMed ID: 8419813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regional cerebral blood flow imaging: a quantitative comparison of technetium-99m-HMPAO SPECT with C15O2 PET.
    Gemmell HG; Evans NT; Besson JA; Roeda D; Davidson J; Dodd MG; Sharp PF; Smith FW; Crawford JR; Newton RH
    J Nucl Med; 1990 Oct; 31(10):1595-600. PubMed ID: 2120397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 99mTc-HMPAO uptake and washout in stroke.
    Bowler JV; Wade JP
    Lancet; 1989 May; 1(8647):1140-1. PubMed ID: 2566082
    [No Abstract]   [Full Text] [Related]  

  • 38. [99mTc]-HM-PAO SPECT in Parkinson's disease.
    Pizzolato G; Dam M; Borsato N; Saitta B; Da Col C; Perlotto N; Zanco P; Ferlin G; Battistin L
    J Cereb Blood Flow Metab; 1988 Dec; 8(6):S101-8. PubMed ID: 3263976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation between triplet repeat expansion and computed tomography measures of caudate nuclei atrophy in Huntington's disease.
    Culjkovic B; Stojkovic O; Vojvodic N; Svetel M; Rakic L; Romac S; Kostic V
    J Neurol; 1999 Nov; 246(11):1090-3. PubMed ID: 10631644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coexistence of cerebral infarct and arteriovenous malformation demonstrated by Tc-99m HMPAO and Tc-99m RBC SPECT imaging.
    Gini A; Holmes RA
    Clin Nucl Med; 1989 Apr; 14(4):303-5. PubMed ID: 2785017
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.